vancomycin has been researched along with Pneumonia, Ventilator-Associated in 40 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (10.00) | 29.6817 |
2010's | 34 (85.00) | 24.3611 |
2020's | 2 (5.00) | 2.80 |
Authors | Studies |
---|---|
Bogner, J; Briegel, J; Draenert, R; Frank, S; Grabein, B; Hinske, L; Irlbeck, M; Jung, J; Kilger, E; Krueger, WA; Liebchen, U; Möhnle, P; Ney, L; Niedermayer, S; Schubert, S; Wang, B; Weber, A; Weig, T; Zoller, M | 1 |
Finnigan, A; Lita, E; Liu, C; Newcomb, AB; Stodghill, J; Teicher, E | 1 |
Aguado, J; Andaluz-Ojeda, D; Blasco-Navalpotro, MA; Del Valle-Ortiz, M; Díaz-Lamas, A; Nuvials-Casals, X; Ortiz-Piquer, M; Ramirez, P; Reig-Valero, R; Roche-Campo, F; Rodriguez-Aguirregabiria, M; Ruiz-Ramos, J; Tamayo-Lomas, L; Vidal-Cortés, P | 1 |
Villanueva, RD; White, BP | 1 |
Cipolla, A; Falcone, M; Mastroianni, CM; Oliva, A; Venditti, M; Vullo, V | 1 |
Bishara, J; Eliakim-Raz, N; Yahav, D | 1 |
Blum, S; Cunha, BA; Jaber, N | 1 |
Bruss, J; Dwyer, J; Jacobs, M; Lacy, MK; Nogid, B | 1 |
Ben-Aicha, S; Fernández-Barat, L; Ferrer, M; Li Bassi, G; Marco, F; Motos, A; Muñoz, L; Rigol, M; Torres, A; Vila, J | 1 |
Abbasi, SA; Ali, Y; Hussain, K; Jamil, B; Khan, AW; Naseem, S; Shah, AA | 1 |
Christmas, AB; Heniford, BT; Norton, HJ; Schmelzer, TM; Sing, RF | 1 |
Kett, DH; Puttagunta, S; Quartin, AA; Scerpella, EG | 1 |
Barriere, SL | 1 |
Blasi, F; Chastre, J; Masterton, RG; Rello, J; Torres, A; Welte, T | 1 |
File, TM; Ford, KD; Kelley, R; Kett, DH; Peyrani, P; Ramirez, JA; Scerpella, EG; Stein, GE; Welch, V; Wiemken, TL; Zervos, MJ | 1 |
Dan, M; Gottesman, T; Lerner, E; Schwartz-Harari, O; Soroksky, A; Yekutieli, D; Yossepowitch, O | 1 |
Chastre, J; Gao, X; Haider, S; Li, JZ; Myers, DE; Niederman, MS; Solem, CT; Stephens, JM; Wan, Y | 1 |
Barriere, SL; Corey, GR; Hardin, TC; Lacy, MK; Luke, DR; Nogid, B; Shorr, AF; Stryjewski, ME; Wang, W | 1 |
Hanes, SD; Kane, SP | 1 |
Bishara, J; Cohen, J; Eliakim-Raz, N; Fisher, S; Hellerman, M; Margalit, I; Shaked, H; Yahav, D; Zusman, O | 1 |
Bhattacharyya, H; Fabian, TC; Leeper, KV; May, AK; Mendelson, MH; Solomkin, JS; Somero, MS; Wunderink, RG | 1 |
Eagye, KJ; Kuti, JL; Nicasio, AM; Nicolau, DP; Palter, M; Pepe, J; Shore, E | 1 |
Niederman, MS | 1 |
McDonald, HC; Pandya, AG; York, NR | 1 |
Allen, M; Cano, E; Haque, NZ; Kett, DH; Lamerato, L; Mangino, JE; Moore, CL; Patel, S; Peterson, E; Peyrani, P; Ramirez, JA; Reyes, K; Wiemken, T; Zervos, MJ; Zuniga, LC | 1 |
Aquino, VR; de Souza Martins, D; dos Santos, RP; Goldani, LZ; Machado, DP; Nagel, F; Nazário, R | 1 |
Sakai, C; Soda, H | 1 |
Albrecht, H | 1 |
Karabekos, D; Karvouniaris, M; Makris, D; Zakynthinos, E | 1 |
Agusti, C; de la Bellacasa, JP; Esperatti, M; Filella, X; Guerrero, L; Li Bassi, G; Liapikou, M; Luque, N; Marco, F; Martinez-Olondris, P; Quera, MA; Rigol, M; Soy, D; Torres, A | 1 |
Kollef, MH | 1 |
Cano, EL; Cely, CM; Ford, KD; Haque, NZ; Kett, DH; Peyrani, P; Ramirez, JA; Scerpella, EG; Welch, VL; Zervos, MJ | 1 |
Agustí, C; Cortadellas, N; Esperatti, M; Fernández-Barat, L; Ferrer, M; Guerrero, L; Li Bassi, G; Luque, N; Martínez-Olondris, P; Rigol, M; Saucedo, LM; Sierra, JM; Soy, D; Torres, A; Vila, J | 1 |
Boucher, BA; Christopher Wood, G; Croce, MA; Fabian, TC; Hamilton, LA; Magnotti, LJ; Martin, JB; Swanson, JM | 1 |
Bassetti, M; Giacobbe, DR; Pelosi, P; Taramasso, L | 1 |
Bubenik, S; Heineman, J; Martindale, R; McClave, S | 1 |
Adams, CA; Cioffi, WG; Connolly, MD; Gregg, S; Heffernan, DS; Monaghan, SF; Stephen, A; Thakkar, RK | 1 |
Allen, J; Brevard, SB; Frotan, MA; Gonzalez, RP; Rostas, J; Simmons, JD | 1 |
Vanni, T | 1 |
Pea, F; Viale, P | 1 |
6 review(s) available for vancomycin and Pneumonia, Ventilator-Associated
Article | Year |
---|---|
European perspective and update on the management of nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus after more than 10 years of experience with linezolid.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Cross Infection; Disease Models, Animal; Europe; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Staphylococcal; Pneumonia, Ventilator-Associated; Practice Guidelines as Topic; Risk Factors; Vancomycin | 2014 |
Unexplained increases in serum vancomycin concentration in a morbidly obese patient.
Topics: Anti-Bacterial Agents; Cross Reactions; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Middle Aged; Obesity, Morbid; Pneumonia, Ventilator-Associated; Vancomycin | 2017 |
Treatment options for nosocomial pneumonia due to MRSA.
Topics: Acetamides; Anti-Bacterial Agents; Cross Infection; Drug Resistance, Multiple, Bacterial; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Staphylococcal; Pneumonia, Ventilator-Associated; Vancomycin | 2009 |
Nosocomial MRSA pneumonia: data from recent clinical trials.
Topics: Acetamides; Anti-Infective Agents; Bronchoalveolar Lavage Fluid; Bronchoscopy; Cross Infection; DNA, Bacterial; Humans; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Staphylococcal; Pneumonia, Ventilator-Associated; Polymerase Chain Reaction; Prognosis; Randomized Controlled Trials as Topic; Risk Factors; Vancomycin | 2011 |
Management of ventilator-associated pneumonia: epidemiology, diagnosis and antimicrobial therapy.
Topics: Anti-Bacterial Agents; Biomarkers; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Incidence; Intensive Care Units; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pneumonia, Ventilator-Associated; Staphylococcal Infections; Vancomycin | 2012 |
Fighting fire with fire: is it time to use probiotics to manage pathogenic bacterial diseases?
Topics: Bacterial Infections; Drug Resistance, Bacterial; Enterococcus; Enterocolitis, Necrotizing; Enterocolitis, Pseudomembranous; Helicobacter Infections; Helicobacter pylori; Humans; Pneumonia, Ventilator-Associated; Probiotics; Vancomycin | 2012 |
6 trial(s) available for vancomycin and Pneumonia, Ventilator-Associated
Article | Year |
---|---|
Vancomycin intermittent dosing versus continuous infusion for treatment of ventilator-associated pneumonia in trauma patients.
Topics: Adult; Anti-Bacterial Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Pneumonia, Ventilator-Associated; Prospective Studies; Treatment Outcome; Vancomycin; Wounds and Injuries; Young Adult | 2013 |
A comparison of microbiology and demographics among patients with healthcare-associated, hospital-acquired, and ventilator-associated pneumonia: a retrospective analysis of 1184 patients from a large, international study.
Topics: Acetamides; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria; Cross Infection; Demography; Female; Humans; Linezolid; Male; Middle Aged; Oxazolidinones; Pneumonia, Ventilator-Associated; Retrospective Studies; Risk Factors; Vancomycin | 2013 |
The ATTAIN trials: efficacy and safety of telavancin compared with vancomycin for the treatment of hospital-acquired and ventilator-associated bacterial pneumonia.
Topics: Adult; Aged; Aged, 80 and over; Aminoglycosides; Anti-Bacterial Agents; Cross Infection; Female; Humans; Lipoglycopeptides; Male; Middle Aged; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Treatment Outcome; Vancomycin | 2014 |
Health economic evaluation of patients treated for nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus: secondary analysis of a multicenter randomized clinical trial of vancomycin and linezolid.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cost-Benefit Analysis; Cross Infection; Double-Blind Method; Drug Costs; Female; Health Resources; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Pneumonia, Staphylococcal; Pneumonia, Ventilator-Associated; Renal Dialysis; Renal Insufficiency; Treatment Outcome; Vancomycin | 2014 |
Telavancin hospital-acquired pneumonia trials: impact of Gram-negative infections and inadequate Gram-negative coverage on clinical efficacy and all-cause mortality.
Topics: Adult; Aminoglycosides; Anti-Bacterial Agents; Coinfection; Cross Infection; Double-Blind Method; Female; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Hospital Mortality; Humans; Lipoglycopeptides; Male; Middle Aged; Pneumonia, Ventilator-Associated; Time Factors; Treatment Outcome; Vancomycin; Young Adult | 2015 |
Early microbiological response to linezolid vs vancomycin in ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Adult; Aged; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Female; Follow-Up Studies; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Pneumonia, Ventilator-Associated; Prospective Studies; Staphylococcal Infections; Time Factors; Treatment Outcome; Vancomycin | 2008 |
28 other study(ies) available for vancomycin and Pneumonia, Ventilator-Associated
Article | Year |
---|---|
Ecological effects of selective oral decontamination on multidrug-resistance bacteria acquired in the intensive care unit: a case-control study over 5 years.
Topics: Adult; Anti-Bacterial Agents; Bacteria; Case-Control Studies; Cross Infection; Decontamination; Humans; Intensive Care Units; Pneumonia, Ventilator-Associated; Vancomycin | 2022 |
Predictive Value of the Methicillin-Resistant
Topics: Adult; Anti-Bacterial Agents; Humans; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Staphylococcal; Pneumonia, Ventilator-Associated; Retrospective Studies; Staphylococcal Infections; Vancomycin | 2021 |
Ventilator-associated pneumonia by methicillin-susceptible Staphylococcus aureus: do minimum inhibitory concentrations to vancomycin and daptomycin matter?
Topics: Aged; Aged, 80 and over; Biomarkers; Comorbidity; Daptomycin; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Ventilator-Associated; Retrospective Studies; Staphylococcal Infections; Treatment Outcome; Vancomycin | 2017 |
Comment on: Trimethoprim/sulfamethoxazole versus vancomycin in the treatment of healthcare/ventilator-associated MRSA pneumonia: a case-control study.
Topics: Anti-Bacterial Agents; Case-Control Studies; Humans; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Ventilator-Associated; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2017 |
Clinical and in vitro efficacy of colistin plus vancomycin and rifampin against colistin-resistant Acinetobacter baumannii causing ventilator-associated pneumonia.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Antibiotics, Antitubercular; Colistin; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Humans; Male; Microbial Sensitivity Tests; Neurosurgical Procedures; Pneumonia, Ventilator-Associated; Rifampin; Subarachnoid Hemorrhage; Vancomycin | 2017 |
Trimethoprim/sulfamethoxazole versus vancomycin in the treatment of healthcare/ventilator-associated MRSA pneumonia: a case-control study-authors' response.
Topics: Anti-Bacterial Agents; Case-Control Studies; Humans; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Ventilator-Associated; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2017 |
Vancomycin or linezolid empiric MRSA coverage with potential ventilator-associated pneumonia has no benefit or effect on outcomes: antibiotic stewardship implications.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antimicrobial Stewardship; Female; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Pneumonia, Ventilator-Associated; Retrospective Studies; Staphylococcal Infections; Treatment Outcome; Vancomycin; Young Adult | 2018 |
Time Course and Extent of Renal Function Changes in Patients Receiving Treatment for Staphylococcal Pneumonias: An Analysis Comparing Telavancin and Vancomycin from the ATTAIN Trials.
Topics: Adult; Aged; Aminoglycosides; Anti-Bacterial Agents; Clinical Trials, Phase III as Topic; Creatinine; Female; Healthcare-Associated Pneumonia; Humans; Kidney Function Tests; Lipoglycopeptides; Male; Middle Aged; Pneumonia, Staphylococcal; Pneumonia, Ventilator-Associated; Randomized Controlled Trials as Topic; Retrospective Studies; Time Factors; Vancomycin | 2018 |
Assessment of in vivo versus in vitro biofilm formation of clinical methicillin-resistant Staphylococcus aureus isolates from endotracheal tubes.
Topics: Animals; Anti-Bacterial Agents; Biofilms; Genotype; Intubation, Intratracheal; Linezolid; Methicillin-Resistant Staphylococcus aureus; Pneumonia, Ventilator-Associated; Prospective Studies; Random Allocation; Swine; Swine Diseases; Time Factors; Vancomycin | 2018 |
Susceptibility pattern of tracheal tube isolates from Intensive Care Unit of Fauji Foundation Hospital Rawalpindi.
Topics: Acinetobacter baumannii; Acinetobacter Infections; Anti-Bacterial Agents; Biofilms; Cross-Sectional Studies; Drug Resistance, Bacterial; Humans; Intensive Care Units; Intubation, Intratracheal; Klebsiella Infections; Klebsiella pneumoniae; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Pakistan; Pneumonia, Ventilator-Associated; Polymyxin B; Pseudomonas Infections; Staphylococcal Infections; Vancomycin | 2019 |
Higher clinical success in patients with ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureus treated with linezolid compared with vancomycin: results from the IMPACT-HAP study.
Topics: Acetamides; Adult; Anemia; Anti-Bacterial Agents; APACHE; Female; Humans; Kidney Diseases; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Ventilator-Associated; Retrospective Studies; Thrombocytopenia; Treatment Outcome; Vancomycin | 2014 |
The accuracy of Gram stain of respiratory specimens in excluding Staphylococcus aureus in ventilator-associated pneumonia.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Coloring Agents; Female; Gentian Violet; Gram-Negative Aerobic Rods and Cocci; Gram-Negative Bacteria; Gram-Positive Cocci; Humans; Male; Middle Aged; Phenazines; Pneumonia, Ventilator-Associated; Prospective Studies; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2014 |
Trimethoprim/sulfamethoxazole versus vancomycin in the treatment of healthcare/ventilator-associated MRSA pneumonia: a case-control study.
Topics: Adult; Aged; Anti-Bacterial Agents; Case-Control Studies; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Staphylococcal; Pneumonia, Ventilator-Associated; Retrospective Studies; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Vancomycin | 2017 |
Pharmacodynamic-based clinical pathway for empiric antibiotic choice in patients with ventilator-associated pneumonia.
Topics: Adult; Aged; Anti-Bacterial Agents; Cefepime; Cephalosporins; Critical Pathways; Drug Administration Schedule; Drug Therapy, Combination; Female; Hospital Mortality; Humans; Intensive Care Units; Length of Stay; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Monte Carlo Method; Observation; Pneumonia, Ventilator-Associated; Prospective Studies; Pseudomonas aeruginosa; Pseudomonas Infections; Thienamycins; Tobramycin; Treatment Outcome; Vancomycin; Young Adult | 2010 |
Drug-induced linear IgA bullous dermatosis demonstrating the isomorphic phenomenon.
Topics: Adult; Drug Eruptions; Humans; Immunoglobulin A; Male; Pneumonia, Ventilator-Associated; Skin Diseases, Vesiculobullous; Vancomycin | 2010 |
Relationship of vancomycin minimum inhibitory concentration to mortality in patients with methicillin-resistant Staphylococcus aureus hospital-acquired, ventilator-associated, or health-care-associated pneumonia.
Topics: Adult; Aged; Aged, 80 and over; Cause of Death; Cross Infection; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Hospital Mortality; Humans; Intensive Care Units; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Ventilator-Associated; Prospective Studies; Staphylococcal Infections; Survival Analysis; Treatment Outcome; Vancomycin | 2010 |
Vancomycin minimal inhibitory concentration from broth microdilution and Etest in respiratory tract samples of patients with ventilation-associated pneumonia.
Topics: Adult; Anti-Bacterial Agents; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Staphylococcal; Pneumonia, Ventilator-Associated; Respiratory System; Vancomycin | 2010 |
Severe ventilator-associated pneumonia caused by methicillin-resistant Staphylococcus aureus and other pathogens: report of a case successfully managed by serial surveillance cultures of endotracheal aspirates.
Topics: Acetamides; Aged; Anti-Bacterial Agents; Bronchoalveolar Lavage; Humans; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Oxazolidinones; Pneumonia, Ventilator-Associated; Respiratory Distress Syndrome; Staphylococcal Infections; Vancomycin | 2011 |
Vancomycin treatment vs comparator drugs.
Topics: Anti-Bacterial Agents; Cross Infection; Humans; Pneumonia, Ventilator-Associated; Staphylococcal Infections; Vancomycin | 2011 |
Efficacy of linezolid compared to vancomycin in an experimental model of pneumonia induced by methicillin-resistant Staphylococcus aureus in ventilated pigs.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Interleukin-6; Interleukin-8; Linezolid; Lung; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Staphylococcal; Pneumonia, Ventilator-Associated; Respiration, Artificial; Swine; Tumor Necrosis Factor-alpha; Vancomycin | 2012 |
Vancomycin for methicillin-resistant Staphylococcus aureus pneumonia: the good, the bad, and the ugly.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Linezolid; Methicillin-Resistant Staphylococcus aureus; Oxazolidinones; Pneumonia, Staphylococcal; Pneumonia, Ventilator-Associated; Vancomycin | 2012 |
Incidence of nephrotoxicity and association with vancomycin use in intensive care unit patients with pneumonia: retrospective analysis of the IMPACT-HAP Database.
Topics: Adult; Aged; Anti-Bacterial Agents; APACHE; Biomarkers; Chi-Square Distribution; Creatinine; Databases as Topic; Female; Humans; Incidence; Intensive Care Units; Kaplan-Meier Estimate; Kidney Diseases; Logistic Models; Male; Middle Aged; Odds Ratio; Pneumonia, Bacterial; Pneumonia, Ventilator-Associated; Retrospective Studies; Risk Assessment; Risk Factors; Time Factors; United States; Vancomycin | 2012 |
Linezolid limits burden of methicillin-resistant Staphylococcus aureus in biofilm of tracheal tubes.
Topics: Acetamides; Animals; Anti-Bacterial Agents; Biofilms; Intubation, Intratracheal; Linezolid; Methicillin-Resistant Staphylococcus aureus; Microscopy, Electron, Scanning; Oxazolidinones; Pneumonia, Staphylococcal; Pneumonia, Ventilator-Associated; Swine; Vancomycin | 2012 |
Treatment of methicillin-resistant Staphylococcus aureus ventilator-associated pneumonia with high-dose vancomycin or linezolid.
Topics: Acetamides; Adult; Aged; Cohort Studies; Critical Illness; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Injury Severity Score; Intensive Care Units; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Pneumonia, Ventilator-Associated; Respiration, Artificial; Retrospective Studies; Risk Assessment; Severity of Illness Index; Staphylococcal Infections; Survival Rate; Trauma Centers; Treatment Outcome; Vancomycin; Wounds and Injuries | 2012 |
Empiric antibiotics pending bronchoalveolar lavage data in patients without pneumonia significantly alters the flora, but not the resistance profile, if a subsequent pneumonia develops.
Topics: Acetamides; Anti-Bacterial Agents; Bronchoalveolar Lavage; Bronchoalveolar Lavage Fluid; Cefepime; Cephalosporins; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Linezolid; Male; Microbial Sensitivity Tests; Middle Aged; Oxazolidinones; Penicillanic Acid; Piperacillin; Pneumonia, Ventilator-Associated; Retrospective Studies; Tazobactam; Treatment Outcome; Vancomycin; Wounds and Injuries | 2013 |
Improved outcome of ventilator-associated pneumonia caused by methicillin-resistant Staphylococcus aureus in a trauma population.
Topics: Acetamides; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Bronchoalveolar Lavage; Female; Humans; Intensive Care Units; Length of Stay; Linezolid; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Oxazolidinones; Pneumonia, Staphylococcal; Pneumonia, Ventilator-Associated; Retrospective Studies; Treatment Outcome; Vancomycin; Wounds, Nonpenetrating | 2013 |
Economic evaluation of linezolid versus vancomycin in mechanical ventilation-associated nosocomial pneumonia caused by methicillin-resistant Staphylococcus aureus.
Topics: Acetamides; Anti-Infective Agents; Cost-Benefit Analysis; Humans; Linezolid; Methicillin Resistance; Oxazolidinones; Pneumonia, Staphylococcal; Pneumonia, Ventilator-Associated; Staphylococcus aureus; Vancomycin | 2006 |
Should the currently recommended twice-daily dosing still be considered the most appropriate regimen for treating MRSA ventilator-associated pneumonia with vancomycin?
Topics: Anti-Bacterial Agents; Area Under Curve; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Methicillin Resistance; Microbial Sensitivity Tests; Pneumonia, Ventilator-Associated; Staphylococcal Infections; Staphylococcus aureus; Vancomycin | 2008 |